Literature DB >> 23372033

Unraveling the molecular events leading to the genesis of large granular lymphocytic leukemia reveals a new treatment strategy.

Todd A Fehniger.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23372033      PMCID： PMC3561419          DOI： 10.3324/haematol.2013.084236

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  6 in total

Review 1.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

2.  Somatic STAT3 mutations in large granular lymphocytic leukemia.

Authors:  Hanna L M Koskela; Samuli Eldfors; Pekka Ellonen; Arjan J van Adrichem; Heikki Kuusanmäki; Emma I Andersson; Sonja Lagström; Michael J Clemente; Thomas Olson; Sari E Jalkanen; Muntasir Mamun Majumder; Henrikki Almusa; Henrik Edgren; Maija Lepistö; Pirkko Mattila; Kathryn Guinta; Pirjo Koistinen; Taru Kuittinen; Kati Penttinen; Alun Parsons; Jonathan Knowles; Janna Saarela; Krister Wennerberg; Olli Kallioniemi; Kimmo Porkka; Thomas P Loughran; Caroline A Heckman; Jaroslaw P Maciejewski; Satu Mustjoki
Journal:  N Engl J Med       Date:  2012-05-17       Impact factor: 91.245

3.  Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia.

Authors:  Li Yu; Chunhui Liu; Jeff Vandeusen; Brian Becknell; Zunyan Dai; Yue-Zhong Wu; Aparna Raval; Te-Hui Liu; Wei Ding; Charlene Mao; Shujun Liu; Laura T Smith; Stephen Lee; Laura Rassenti; Guido Marcucci; John Byrd; Michael A Caligiuri; Christoph Plass
Journal:  Nat Genet       Date:  2005-02-20       Impact factor: 38.330

Review 4.  T-cell and natural killer-cell large granular lymphocyte leukemia neoplasias.

Authors:  Rebecca J Watters; Xin Liu; Thomas P Loughran
Journal:  Leuk Lymphoma       Date:  2011-07-13

5.  Aberrant overexpression of IL-15 initiates large granular lymphocyte leukemia through chromosomal instability and DNA hypermethylation.

Authors:  Anjali Mishra; Shujun Liu; Gregory H Sams; Douglas P Curphey; Ramasamy Santhanam; Laura J Rush; Deanna Schaefer; Lauren G Falkenberg; Laura Sullivan; Laura Jaroncyk; Xiaojuan Yang; Harold Fisk; Lai-Chu Wu; Christopher Hickey; Jason C Chandler; Yue-Zhong Wu; Nyla A Heerema; Kenneth K Chan; Danilo Perrotti; Jianying Zhang; Pierluigi Porcu; Frederick K Racke; Ramiro Garzon; Robert J Lee; Guido Marcucci; Michael A Caligiuri
Journal:  Cancer Cell       Date:  2012-11-13       Impact factor: 31.743

6.  Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells.

Authors:  T A Fehniger; K Suzuki; A Ponnappan; J B VanDeusen; M A Cooper; S M Florea; A G Freud; M L Robinson; J Durbin; M A Caligiuri
Journal:  J Exp Med       Date:  2001-01-15       Impact factor: 14.307
  6 in total
  1 in total

1.  Shp-2 is critical for ERK and metabolic engagement downstream of IL-15 receptor in NK cells.

Authors:  Charlène Niogret; S M Shahjahan Miah; Giorgia Rota; Nicolas P Fonta; Haiping Wang; Werner Held; Walter Birchmeier; Veronica Sexl; Wentian Yang; Eric Vivier; Ping-Chih Ho; Laurent Brossay; Greta Guarda
Journal:  Nat Commun       Date:  2019-03-29       Impact factor: 14.919
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.